XLerateHealth is enterprise-focused and will help early stage healthcare companies build out their commercialisation strategy.
XLerateHealth has raised $3.3M in total funding. The most recent round was Grant. The last funding was announced in August 2022.
XLerateHealth's investors include National Institutes of Health.
XLerateHealth is headquartered in Louisville, United States.
XLerateHealth is enterprise-focused and will help early stage healthcare companies build out their commercialisation strategy.
XLerateHealth is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"XLerateHealth — Funding & Investors." VCBacked, August 18, 2022, https://www.vcbacked.co/company/xleratehealth. Accessed September 30, 2026.
VCBacked. (2022). XLerateHealth — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/xleratehealth
{{cite web |title=XLerateHealth — Funding & Investors |url=https://www.vcbacked.co/company/xleratehealth |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated